Egis Pharmaceuticals Plc Is A Leading Pharmaceutical Company In Central Eastern Europepart Of Theservier Groupwhich Is Based In Francethecompany Operates In 10 Countries And Has Subsidiaries And Offices In 18 Countriesfor The202 2024 Financial Yearegis Reported Net Sales Of A 692 7 Million Egis Manages Theentirepharmaceutical Valuechainincluding Research And Developmentactivepharmaceutical Ingredientapiproductionfinished Product Manufacturingand Global Distributionthecompany Offers A Diverseportfolio Of 652 Products Across 170 Product Linesfocusing On Therapeutic Areas Such As Cardiovascular Diseasescentral Nervous System Disordersdiabetologydermatologyand Wound Careegis Is Also Known For Its Biosimilarshaving Launched Several Eu Approved Biosimilar Drugsthecompany Emphasizes Innovativetechnologies And Quality Control In Its Manufacturing Processesensuring Cost Efficient Generic Formulations And Complex Api Synthesisegis Is Committed To Healthcareaccessibility And Community Development Through Scientific Collaborationsmedical Education Programsand Social Initiatives
